These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23256768)

  • 1. Sodium-proton exchanger isoform-1: synthesis of a potent inhibitor labeled with deuterium and carbon-14.
    Latli B; Haddad N; Hrapchak M; Wei X; Tang W; Song JJ; Senanayake CH
    Curr Radiopharm; 2013 Mar; 6(1):7-11. PubMed ID: 23256768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of a potent cathepsin s inhibitor labeled with deuterium and carbon-14.
    Latli B; Hrapchak M; Lorenz JC; Busacca CA; Senanayake C
    Curr Radiopharm; 2012 Oct; 5(4):314-7. PubMed ID: 22724423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (5-Arylfuran-2-ylcarbonyl)guanidines as cardioprotectives through the inhibition of Na+/H+ exchanger isoform-1.
    Lee S; Yi KY; Hwang SK; Lee BH; Yoo SE; Lee K
    J Med Chem; 2005 Apr; 48(8):2882-91. PubMed ID: 15828827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1.
    Ahmad S; Doweyko LM; Dugar S; Grazier N; Ngu K; Wu SC; Yost KJ; Chen BC; Gougoutas JZ; DiMarco JD; Lan SJ; Gavin BJ; Chen AY; Dorso CR; Serafino R; Kirby M; Atwal KS
    J Med Chem; 2001 Sep; 44(20):3302-10. PubMed ID: 11563929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoimidazoles as bioisosteres of acylguanidines: novel, potent, selective and orally bioavailable inhibitors of the sodium hydrogen exchanger isoform-1.
    Ahmad S; Ngu K; Combs DW; Wu SC; Weinstein DS; Liu W; Chen BC; Chandrasena G; Dorso CR; Kirby M; Atwal KS
    Bioorg Med Chem Lett; 2004 Jan; 14(1):177-80. PubMed ID: 14684323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel five-lipoxygenase activity protein inhibitor labeled with carbon-14 and deuterium.
    Latli B; Hrapchak M; Gao JJ; Busacca CA; Senanayake CH
    J Labelled Comp Radiopharm; 2015 Jul; 58(9):390-4. PubMed ID: 26190342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent IκB kinase-β inhibitor labeled with carbon-14 and deuterium.
    Latli B; Eriksson M; Hrapchak M; Busacca CA; Senanayake CH
    J Labelled Comp Radiopharm; 2016 Jun; 59(8):300-4. PubMed ID: 27073120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1).
    Tracey WR; Allen MC; Frazier DE; Fossa AA; Johnson CG; Marala RB; Knight DR; Guzman-Perez A
    Cardiovasc Drug Rev; 2003; 21(1):17-32. PubMed ID: 12595915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the rat.
    Huber JD; Bentzien J; Boyer SJ; Burke J; De Lombaert S; Eickmeier C; Guo X; Haist JV; Hickey ER; Kaplita P; Karmazyn M; Kemper R; Kennedy CA; Kirrane T; Madwed JB; Mainolfi E; Nagaraja N; Soleymanzadeh F; Swinamer A; Eldrup AB
    J Med Chem; 2012 Aug; 55(16):7114-40. PubMed ID: 22803959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of aroylguanidines related to amiloride as inhibitors of the human platelet Na(+)/H(+) exchanger.
    Laeckmann D; Rogister F; Dejardin JV; Prosperi-Meys C; Géczy J; Delarge J; Masereel B
    Bioorg Med Chem; 2002 Jun; 10(6):1793-804. PubMed ID: 11937337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Na(+)/H(+)exchangers: linking osmotic dysequilibrium to modified cell function.
    Ritter M; Fuerst J; Wöll E; Chwatal S; Gschwentner M; Lang F; Deetjen P; Paulmichl M
    Cell Physiol Biochem; 2001; 11(1):1-18. PubMed ID: 11275678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Na+/H+ exchanger isoforms in normal human nasal epithelial cells and functional activity of Na+/H+ exchanger 1 in intracellular pH regulation.
    Shin JH; Namkung W; Kim CH; Choi JY; Yoo JB; Lee KD; Lee JG; Lee MG; Yoon JH
    Acta Otolaryngol; 2005 Mar; 125(3):286-92. PubMed ID: 15966699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Na(+)/H(+) exchanger: a target for cardiac therapeutic intervention.
    Karmazyn M; Sawyer M; Fliegel L
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Aug; 5(4):323-35. PubMed ID: 16101565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drugs for the Na+/H+ exchanger. Influence of Na+ concentration and determination of inhibition constants with a microphysiometer.
    Fischer H; Seelig A; Beier N; Raddatz P; Seelig J
    J Membr Biol; 1999 Mar; 168(1):39-45. PubMed ID: 10051688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the human sodium/proton exchanger NHE-1 in Xenopus laevis oocytes enhances sodium/proton exchange activity and establishes sodium/lithium countertransport.
    Busch S; Burckhardt BC; Siffert W
    Pflugers Arch; 1995 Apr; 429(6):859-69. PubMed ID: 7603840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of inhibitors of Na(+)/H(+) exchanger.
    Masereel B; Pochet L; Laeckmann D
    Eur J Med Chem; 2003 Jun; 38(6):547-54. PubMed ID: 12832126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of zoniporide: a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility.
    Guzman-Perez A; Wester RT; Allen MC; Brown JA; Buchholz AR; Cook ER; Day WW; Hamanaka ES; Kennedy SP; Knight DR; Kowalczyk PJ; Marala RB; Mularski CJ; Novomisle WA; Ruggeri RB; Tracey WR; Hill RJ
    Bioorg Med Chem Lett; 2001 Mar; 11(6):803-7. PubMed ID: 11277524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and selective inhibition of the human Na+/H+ exchanger isoform NHE1 by a novel aminoguanidine derivative T-162559.
    Kawamoto T; Kimura H; Kusumoto K; Fukumoto S; Shiraishi M; Watanabe T; Sawada H
    Eur J Pharmacol; 2001 May; 420(1):1-8. PubMed ID: 11412833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (2-Methyl-5-(methylsulfonyl)benzoyl)guanidine Na+/H+ antiporter inhibitors.
    Baumgarth M; Beier N; Gericke R
    J Med Chem; 1997 Jun; 40(13):2017-34. PubMed ID: 9207943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and transient sodium-hydrogen exchanger isoform 1 inhibition attenuates subsequent cardiac hypertrophy and heart failure following coronary artery ligation.
    Kilić A; Huang CX; Rajapurohitam V; Madwed JB; Karmazyn M
    J Pharmacol Exp Ther; 2014 Dec; 351(3):492-9. PubMed ID: 25216745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.